Plain-English translation of NCT07353775 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is evaluating a new circular-shaped pulsed field ablation catheter — a specialized medical device designed to treat abnormal heart rhythms like atrial fibrillation and atrial flutter. Doctors will use ultrasound imaging from inside your heart to guide the catheter to a specific area that needs treatment. The study wants to understand whether this new tool is effective and safe for this heart procedure.
Abnormal heart rhythms affect many people and can increase the risk of stroke and other complications. Doctors currently use several techniques to treat these rhythms, but this study is exploring whether this new catheter technology might offer a better or safer option.
You likely qualify if…
You likely don't qualify if…
You would undergo the planned ablation procedure using this new circular-shaped catheter device, guided by ultrasound imaging from inside your heart. The doctors will monitor you during the procedure to evaluate how well the tool works and watch for any safety concerns. The study will track your outcomes to determine whether this new technology is both effective and safe for treating your heart rhythm.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China
Sponsor
Beijing Anzhen Hospital
Enrollment target
~150 participants
Started
January 2025
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Song Zuo, Doctoral
Beijing Anzhen Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.